Sunday, March 3, 2024

Hillman Cancer Center Pittsburgh Pa

Upmc Hillman Mesothelioma Specialists

Living With Melanoma – UPMC Hillman Cancer Center | Pittsburgh, PA

The Mesothelioma Specialty Care program employs a multimodality treatment approach, incorporating combinations of surgery, chemotherapy and radiation therapy. These therapies also include a form of heated chemotherapy that is used in conjunction with a pleurectomy .

Among the teams experts are surgical oncologists who specialize in treating different types of mesothelioma, including James F. Pingpank, M.D., a peritoneal specialists who treats the cancer with surgery and chemotherapy.

The surgeons treating pleural mesothelioma within the specialty center include Neil Christie, M.D., who specializes in minimally invasive thoracic surgery and Matthew Schuchert, M.D., who specializes in radiofrequency ablation, CyberKnife and all facets of thoracic surgical oncology.

In treating pleural mesothelioma, Christie and Schuchert are joined by James Luketich, M.D., chairman of the Cardiothoracic Surgery department.

Proud History Of Excellence At Upmc

Founded in 1985, the University of Pittsburgh Cancer Institute was the youngest cancer center ever to receive the NCIs elite award, proving its excellence in patient care, education, basic science, clinical research and cancer prevention.

Today, UPMC offers one of the largest integrated community networks of cancer physicians and health care specialists in the nation. The facilities recruiting success has resulted in increased government funding. In 2010, the UPCI received nearly $170 million. Ranked among the countrys top-tier cancer institutes, the UPMC is continually recognized by U.S. News & World Report as having one of the nations best cancer programs.

Disclaimer: Watch Our Free Mesothelioma Webinars

  • 5115 Centre Ave Pittsburgh, PA 15224

Upmcs Acclaimed Lung Cancer Program

The Lung and Esophageal Cancer Treatment Program, which has received much acclaim, is comprised of internationally renowned thoracic surgeons, medical oncologists, radiation oncologists, pulmonologists and pathologists.

The success of the program is due to the hard work and experience of its doctors and researchers like Schuchert, assistant professor of surgery for the Department of Cardiothoracic Surgery and an authority in thoracic surgical oncology and research. This team utilizes an interdisciplinary and coordinated approach, whether treating mesothelioma or non-small and small-cell lung cancers.

Don’t Miss: Is Chemo Or Radiation Worse

Research At Upmc Hillman Cancer Center

Our members include more than 300 researchers across seven programs, including biobehavioral cancer control, cancer biology, cancer epidemiology and prevention, cancer immunology and immunotherapy, cancer therapeutics, cancer virology, and genome stability. We hold Specialized Programs of Research Excellence awards in head and neck cancer and skin cancer, as well as a joint SPOREs award with Roswell Park Comprehensive Cancer Center for ovarian cancer.

Hillman investigators have access to cutting-edge equipment, technology, and expertise through 10 Cancer Center Support Grant-supported shared resources ranging from biostatistics and bioinformatics to genomic sequencing, cell and tissue imaging, and pharmacology. Many Hillman researchers are based at the centers flagship location, UPMC Hillman Cancer Center in Shadyside, a state-of-the-art facility that supports collaborative performance of laboratory research, clinical research, routine clinical care, and population science program administration for maximum efficiency and patient benefit.

Hillman currently offers more than 450 clinical trials, including large late-phase trials sponsored by NCIs National Clinical Trials Network, industry-sponsored studies, and trials designed and sponsored by Hillman investigators.

Robotic Surgery: Extending The Surgeons Reach

Hillman Cancer Center Address

Robotic techniques are minimally invasive procedures that can help reduce the trauma and invasiveness of traditional open-abdominal surgery for PD. Robotic surgery is what people call it, but thats really a misnomer, says Amer H. Zureikat, MD, chief of the Division of Gastrointestinal Surgical Oncology at UPMC Hillman Cancer Center. The robot is actually a computer platform with tools that guide the surgeons hand. It gives you magnification, accuracy, and stability so you can do the surgery without opening the abdomen.

Nearly 600 robotic Whipple procedures have been performed at UPMC since 2008, when it began studying the benefits of this less invasive approach for PD surgery. The results are encouraging: Dr. Zureikats team found that complication rates for the robotic Whipple were nearly 30 percent less when compared to nationwide statistics for the traditional open version of the procedure.

Recommended Reading: Chemo For Pancreatic Cancer Stage 4

Learn Which Patient Portal Is Right For You

Our patient portals allow you to conveniently schedule a video visit with a UPMC specialtist. Choose the patient portal that’s right for you.

200 Lothrop Street

Your health information, right at your fingertips. Select MyUPMC to access your UPMC health information. For patients of UPMC-affiliated doctors in Central Pa, select UPMC Central Pa Portal. Patients of UPMC Cole should select the UPMC Cole Connect Patient Portal.

The portal for all UPMC patients EXCEPT those in Central Pa.

About Research At Upmc Hillman Cancer Center

UPMC Hillman Cancer Center is a National Cancer Institute -designated Comprehensive Cancer Center – one of only 53 in the U.S.

At UPMC Hillman Cancer Center, our researchers collaborate with our clinician-scientists to advance the most promising laboratory studies into novel clinical trials in order to provide patients with early access to new and innovative treatments.

The nationally and internationally renowned research at UPMC Hillman Cancer Center includes a range of disciplines, from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end-of-life care.

We are also dedicated to the education and training of the next generation of cancer researchers and physicians, as well as the ongoing recruitment of world-renowned scientists.

UPMC Hillman Cancer Center is the only NCI-designated Comprehensive Cancer Center in western Pennsylvania. We are dedicated to excellence for our patients, and we are working to make vast strides in the global effort to reduce the burden of cancer.

Don’t Miss: Natural Remedies For Neuropathy From Chemo

Upmc Hillman Cancer Center Gala

The UPMC Hillman Cancer Center Gala will be held on Thursday, September 15, 2022, at PPG Paints Arena. This spectacular event recognizes those who have helped to raise millions of dollars in support of UPMC Hillman Cancer Centers fight against cancer. The event is one of the most vital and visible events in our city, and is a celebration of the advancements that are being made daily right here in Pittsburgh.

Our team has established a standard of excellence in cancer research and patient care that reaches far beyond Pittsburgh. To continue this excellent work, we rely on support from our community partners, our private and corporate supporters and from individuals like you. We look forward to celebrating with you in person in September!

End Points And Statistical Plan

UPMC Hillman Cancer Center Available To All Patients

The primary end point of phase 2 for cohort A is time to ctDNA positivity, which is defined as the time from randomization to the first ctDNA-positive result after randomization to Arm 1 and the second ctDNA-positive result after randomization to Arm 2. The difference in definition of ctDNA positivity for Arm 1 and Arm 2 allows for the possibility that delayed chemotherapy on Arm 2 could seroconvert the patient back to negative ctDNA. Recurrence without a positive ctDNA result will be considered as an event for the primary end point for both arms . The last ctDNA test will be used to censor patients without any postrandomization positive ctDNA results. Patients with only 1 positive ctDNA result in Arm 2 will be censored at the last ctDNA test. The primary end point of phase 3 for cohort A and of phase 2/3 for cohort B is DFS, which is defined as time from randomization to recurrence or death from any cause.

Read Also: Pictures Of Stage 1 Lung Cancer

Treating Pleural & Peritoneal Mesothelioma At Upmc Cancer Center

The Mesothelioma Specialty Care program treats the two most common types of mesothelioma, pleural and peritoneal, which affect the linings of the lung and abdomen, respectively.

Accurate diagnostic measures set the foundation for treatment at UPMC. A variety of cutting-edge imaging scans and biopsy tests are used to determine the cancers stage and cell type, which help guide treatment decisions.

Comprehensive treatment planning and surgical services form the cornerstone of care at UPMC. A team of doctors specializing in surgery, chemotherapy, radiation therapy, oncology, pain management and palliative care work together to devise a customized treatment and health care plan for each patient.

New patients are guided by a UPMC coordinator, who will schedule appointments and serve as liaison for the patient and treatment team.

Upmc Hillman Cancer Center Patient Hotel

The UPMC Hillman Cancer Center is located a little under a mile from your suite. Patients and visitors to the hospital qualify for special rates when staying at Shadyside Inn. Park for free at our apartment and use our free shuttle service to get back and forth to the facility. Special extended-stay pricing offers some of the lowest rates in the area.

The University of Pittsburgh Cancer Institute is a National Cancer Institute -designated Comprehensive Cancer Center located in the Hillman Cancer Center in the Shadyside neighborhood of Pittsburgh, Pennsylvania, United States. The only NCI-designated cancer center in Western Pennsylvania, UPCI is composed of collaborative academic and research efforts between the University of Pittsburgh, the University of Pittsburgh Medical Center , and Carnegie Mellon University.

Recommended Reading: Can You Have Radiation More Than Once

Expert Cancer Care At Upmc Hillman Cancer Center

At UPMC Hillman Cancer Center, we’re committed to giving you the knowledge, inspiration, and specialty care you need to boldly face your cancer. Because no diagnosis should stop you from doing the things you love, or from living each day to the fullest.

We are the region’s only comprehensive cancer center designated by the National Cancer Institute. And with more than 70 UPMC Hillman Cancer Center locations, you won’t have to travel far to receive world-class treatments backed by best practices and leading-edge protocols.

Hillman remains open for care, and is taking every precaution to keep our patients, their families, and our staff safe. Read the message from our leadership about COVID-19.

Learn more about who we are and how we can help you.

One Plus One Is Three

New Meditation Room at Hillman Cancer Center a Calming Space for Staff ...

What is most interesting to Dr. Zureikat and his research team is the apparent synergy these two innovations create when applied together in PD cases. The study, which compared length of stay statistics for various combinations of robotic surgery and ERAS, indicated that applying the two together may provide the optimal condition for improved PD outcomes.

Dr. Zureikat cautions that more research is necessary to verify these results, which are based on a small sampling of cases. Nevertheless, the indicators are there. It could be a case of one plus one equals three, says Dr. Zureikat. He theorizes that the additional benefit may be due to the additive effect that minimally invasive surgery has on limiting physiologic stress and preserving immune function, in addition to the known benefits of ERAS management.

It all adds up to a quicker recovery and a shorter hospital stay for PD patients. Its not just the cost, adds Dr. Zureikat. A shorter stay in the hospital gets patients back to work, back to their families, and back to their lives sooner. Its just better medicine.

Editor’s Note: This article was originally published on February 25, 2019, and was last reviewed on April 11, 2022

Read Also: West Cancer Center Wolf River

How Your Gift Can Make A Difference

UPMC Hillman Cancer Center provides the most compassionate, sophisticated care to cancer patients from the tristate region and beyond. With our broad network of community cancer physicians, and the Hillman Cancer Center serving as our flagship site, we offer patients the latest advances in cancer detection, prevention, diagnosis, and treatment services. Our researchers are making important discoveries in the laboratory and are working diligently to advance their scientific findings into new and innovative treatments for patients.

As long as cancer continues to be a major health care concern, there will be a commensurate need for philanthropy to ensure that UPMC Hillman Cancer Center remains a world-class institution with state-of-the-art equipment, innovative medical programs, effective screening and prevention technologies, and compassionate support systems for patients and their families.

For more information or to inquire about other possibilities for giving, please call us at 412-623-4700.

UPMC Hillman Cancer Center welcomes the opportunity to discuss the range of ways in which you can donate to various patient care and research efforts.

About Zahra Rahman Kelly

Zahra Rahman Kelly, DO, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Kelly is trained in the management of all cancers and blood disorders with a focus in genitourinary and head and neck malignancies. Dr. Kelly is board-certified in nternal medicine and medical oncology and hematology. She received her medical degree from Philadelphia College of Osteopathic Medicine. Dr. Kelly completed both a residency in internal medicine and a fellowship in hematology/oncology at UPMC. She served as chief fellow during her final year of hematology/oncology fellowship.Her research interests include early phase clinical trial design and cancer immunotherapy combination trials. She has published papers in peer reviewed journals and is an active member of the UPMC Hillman protocol review committee where she reviews therapeutic oncology trials. She also collaborates with surgical oncologists and radiation oncologists to provide multidisciplinary care to her patients.Dr. Kelly is a member of the European Society of Medical Oncology, American Society of Medical Oncology, American Medical Association, and American Society of Hematology.

Also Check: Stage 3 Cervical Cancer Life Expectancy

Upmc Hillman Cancer Center Top Doctors

Nearly 400 UPMC physicians have been recognized as 2022 “Top Doctors” across more than 60 different specialties. UPMC doctors represent more than half of the physicians on this years list.

The majority of our oncologists were recognized under the fields of Medical, Radiation, and Surgery, however, many were recognized under their specific treatment field, such as Otolaryngology, Neurosurgery, and more. We congratulate all of our oncologists who were recognized as Top Doctors this year.

These physicians are part of the Top Doctors® list, which is compiled by Castle Connolly. The Castle Connolly Top Doctor selection process is entirely merit-based. Doctors cannot pay to be listed. Castle Connollys peer-to-peer nominations and rigorous research process ensure only the most qualified physicians are included.

Specialized Mesothelioma Care At Upmc Cancer Center

Clinical Trial Phases | UPMC Hillman Cancer Center

The UPMC Cancer Center network has been recognized as a national leader for many years, earning a reputation for excellence through a vast range of services and a quality of care that is unmatched in Western Pennsylvania.

The Mesothelioma Specialty Care program was added in 2011, joining the growing list of common and rare cancers covered under the UPMC umbrella. This and other specialized programs at UPMC give each patient a comprehensive, individualized care package with a multidisciplinary approach.

Cancer patients of all kinds are in good hands here, reaping the collective expertise that comes from several hundred health care professionals and research scientists, 200 affiliated oncologists and 35 satellite centers. It is one of the largest and most extensive cancer-care networks in the country.

With the Hillman Cancer Center as the flagship facility and the home of the University of Pittsburgh Cancer Institute, patients are assured of getting the most current and effective advances in prevention, detection, diagnosis and treatment. And with so many medical and academic resources available, the latest and greatest developments are never far away.

UPMC is a nonprofit health care provider. As a nonprofit, all the money it makes is reinvested back into the health care services it provides, including the Mesothelioma Specialty Care program.

You May Like: Bladder Cancer Pictures From Cystoscopy

Upmc Mesothelioma Clinical Trials

  • A multicenter phase II clinical trial studying the effectiveness of the Opdivo and Yervoy immunotherapy combination with various rare cancers. Opdivo is given on days 1, 15 and 29, while Yervoy is given only on the first day.
  • A phase I study of atezolizumab, an immunotherapy drug, in combination with chemotherapy, aggressive surgery and with or without radiation therapy. The experimental drug will be given both before and after surgery.
  • This randomized phase I/II clinical trial will be measuring the safest dosage levels of anetumab ravtansine when used in combination with Keytruda for unresectable pleural mesothelioma.

Currently, UPMC is participating in one mesothelioma clinical trial involving chemotherapy with pemetrexed, also known as Alimta. The trial is evaluating the potential benefit of administering pemetrexed every 21 days after first-line chemotherapy as a means to control or prevent tumor growth and spreading. The study began in April 2010 and is estimated to wrap up in 2020.

Upmc Hillman Cancer Center

Washington Health System Cancer Care provides a coordinated program of care encompassing surgery, chemotherapy, radiation therapy, inpatient care, hospice and palliative care, mammography, education, support groups, and more. This includes prevention, detection, treatment, support and education. All are a vital part of the process.

Washington Health System Cancer Center is in partnership with UPMC Hillman Cancer Center to bring state-of-the-art radiation therapy, improved diagnostic capabilities, and other support services to residents in our communities. With this partnership, patients have convenient access to treatments, such as respiratory gating and intensity-modulated radiation therapy , the most advanced radiation therapy available, as well as the full resources of UPMC Hillman Cancer Center facilities, without always having to travel. As part of the UPMC Hillman Cancer Center network, one of the largest integrated cancer networks in the nation, and western Pennsylvanias only NCI-designated Comprehensive Cancer Center, patients have access to the latest cancer treatment trials, as well as the research activities at UPMC.

WHS Washington Hospital

155 Wilson Ave, Washington, PAPhone: 223-3788

Part of Magee-Womens Hospital of UPMC

470 Johnson Rd, Washington, PAPhone: 223-3816

Medical Oncology

Patients are provided with exceptional care through the entire course and treatment of their disease. Our many services include:

Radiation Therapy

IMRT

You May Like: What To Eat After Chemo

Eras: Focusing On Recovery From The Beginning

But a reduction in complications alone doesnt lead to shorter hospital stays. Dr. Zureikat is studying ERAS as another innovation to help patients get back on their feet sooner.

Over the last decade, ERAS has been associated with reductions in length of hospital stay and cost across a wide range of surgical specialties, including colorectal, urologic, and bariatric procedures. Increasingly, ERAS pathways are being applied to pancreatic surgery on the theory that it can be even more beneficial for these complex procedures.

ERAS care plans are structured, evidence-based pathways designed to limit physiological stress and expedite patient recovery. They commonly focus on three aspects of care after surgery: the use of more than one method for pain management, the early delivery of food , and a focus on getting patients out of bed and engaged in light activity as soon as possible.

At UPMC, ERAS care minimizes the use of narcotics for pain management, favoring alternatives wherever possible. With lower levels of narcotics in their system, patients are able to digest food and get exercise sooner after surgery, speeding recovery. UPMCs pioneering application of the ERAS protocol for PD limits narcotics to a single spinal dose of morphine for surgery, followed by alternative pain relief.

Latest news
Related news